2 results match your criteria: "University of Arizona College of Medicine and Division of Gastroenterology and Hepatology[Affiliation]"

Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria.

Commun Med (Lond)

October 2024

Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Article Synopsis
  • - The 2023 nomenclature for steatotic liver disease (SLD) encompasses metabolic dysfunction-associated SLD (MASLD), alcohol-associated liver disease (ALD), and a mix of both (MetALD), prompting a study on racial and ethnic disparities in SLD prevalence among US adults.
  • - Data from the 2017-2018 National Health and Nutrition Examination Survey (NHANES) revealed that 42.4% of participants had MASLD, while the rates for MetALD and ALD were significantly lower (1.7% and 0.6%, respectively), with a higher prevalence observed in Hispanic individuals.
  • - Factors such as male gender, age, higher BMI, and various
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the significant burden of alcohol-related issues like liver disease and alcohol use disorder (AUD) among young women, a demographic identified as particularly vulnerable compared to men.
  • Utilizing data from the Global Burden of Disease Study 2019, researchers analyzed prevalence, mortality, and disability-adjusted life years of alcohol-associated cirrhosis, liver cancer from alcohol, and AUD in young women, with findings organized by region and sociodemographic factors.
  • Results show that AUD has the highest prevalence rates, followed by alcohol-associated cirrhosis and liver cancer; Central Europe shows the highest burdens, indicating an urgent need for targeted public health strategies to address these issues in young women.
View Article and Find Full Text PDF